Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects
NCT02681055
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-alcoholic Steatohepatitis
Hypertriglyceridemia
Non-alcoholic Fatty Liver Disease
Hypercholesterolemia
Interventions
DRUG:
MN-001
Sponsor
MediciNova